These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 38551385)

  • 41. Massively parallel sequencing: the new frontier of hematologic genomics.
    Johnsen JM; Nickerson DA; Reiner AP
    Blood; 2013 Nov; 122(19):3268-75. PubMed ID: 24021669
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The genome clinic: a multidisciplinary approach to assessing the opportunities and challenges of integrating genomic analysis into clinical care.
    Bowdin S; Ray PN; Cohn RD; Meyn MS
    Hum Mutat; 2014 May; 35(5):513-9. PubMed ID: 24599881
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genomics-Enabled Precision Medicine for Cancer.
    Roos A; Byron SA
    Cancer Treat Res; 2019; 178():137-169. PubMed ID: 31209844
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Next-Generation Sequencing: The Translational Medicine Approach from "Bench to Bedside to Population".
    Beigh MM
    Medicines (Basel); 2016 Jun; 3(2):. PubMed ID: 28930123
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care.
    Miller FA; Hayeems RZ; Bytautas JP; Bedard PL; Ernst S; Hirte H; Hotte S; Oza A; Razak A; Welch S; Winquist E; Dancey J; Siu LL
    Eur J Hum Genet; 2014 Mar; 22(3):391-5. PubMed ID: 23860039
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Exome Sequencing in Clinical Hepatology.
    Vilarinho S; Mistry PK
    Hepatology; 2019 Dec; 70(6):2185-2192. PubMed ID: 31222768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.
    Perera-Bel J; Hutter B; Heining C; Bleckmann A; Fröhlich M; Fröhling S; Glimm H; Brors B; Beißbarth T
    Genome Med; 2018 Mar; 10(1):18. PubMed ID: 29544535
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-throughput sequencing in clinical oncology: from past to present.
    Mery B; Vallard A; Rowinski E; Magne N
    Swiss Med Wkly; 2019 Mar; 149():w20057. PubMed ID: 30946479
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opportunities, resources, and techniques for implementing genomics in clinical care.
    Manolio TA; Rowley R; Williams MS; Roden D; Ginsburg GS; Bult C; Chisholm RL; Deverka PA; McLeod HL; Mensah GA; Relling MV; Rodriguez LL; Tamburro C; Green ED
    Lancet; 2019 Aug; 394(10197):511-520. PubMed ID: 31395439
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomics: the power, potential and pitfalls of the new technologies and how they are transforming healthcare.
    Josephs KS; Berner A; George A; Scott RH; ; Firth HV; Tatton-Brown K
    Clin Med (Lond); 2019 Jul; 19(4):269-272. PubMed ID: 31308101
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Clinical pharmacogenomics testing in the era of next generation sequencing: challenges and opportunities for precision medicine.
    Ji Y; Si Y; McMillin GA; Lyon E
    Expert Rev Mol Diagn; 2018 May; 18(5):411-421. PubMed ID: 29634383
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Genomic medicine].
    Nielsen FC
    Ugeskr Laeger; 2019 Apr; 181(7A):. PubMed ID: 30950375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cancer genomics and inherited risk.
    Stadler ZK; Schrader KA; Vijai J; Robson ME; Offit K
    J Clin Oncol; 2014 Mar; 32(7):687-98. PubMed ID: 24449244
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Genomics: Challenges and Opportunities.
    Vijay P; McIntyre AB; Mason CE; Greenfield JP; Li S
    Crit Rev Eukaryot Gene Expr; 2016; 26(2):97-113. PubMed ID: 27480773
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Single-Cell Sequencing in Precision Medicine.
    Wiedmeier JE; Noel P; Lin W; Von Hoff DD; Han H
    Cancer Treat Res; 2019; 178():237-252. PubMed ID: 31209848
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comprehensive genomic profiling for oncological advancements by precision medicine.
    Pankiw M; Brezden-Masley C; Charames GS
    Med Oncol; 2023 Nov; 41(1):1. PubMed ID: 37993657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
    Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
    Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The genomic landscape of pediatric acute lymphoblastic leukemia and precision medicine opportunities.
    Tran TH; Hunger SP
    Semin Cancer Biol; 2022 Sep; 84():144-152. PubMed ID: 33197607
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetics, genomics, and cancer risk assessment: State of the Art and Future Directions in the Era of Personalized Medicine.
    Weitzel JN; Blazer KR; MacDonald DJ; Culver JO; Offit K
    CA Cancer J Clin; 2011; 61(5):327-59. PubMed ID: 21858794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.